Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Fibroblast-activation protein: valuable marker of cutaneous epithelial malignancy.

El Khoury J, Kurban M, Kibbi AG, Abbas O.

Arch Dermatol Res. 2014 May;306(4):359-65. doi: 10.1007/s00403-014-1456-8. Epub 2014 Mar 5.

PMID:
24595644
2.

Fibroblast-activation protein: a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepithelioma.

Abbas O, Richards JE, Mahalingam M.

Mod Pathol. 2010 Nov;23(11):1535-43. doi: 10.1038/modpathol.2010.142. Epub 2010 Aug 13.

3.
4.

Microcystic adnexal carcinoma: an immunohistochemical reappraisal.

Hoang MP, Dresser KA, Kapur P, High WA, Mahalingam M.

Mod Pathol. 2008 Feb;21(2):178-85. Epub 2007 Dec 7.

5.

Effects of the fibroblast activation protein on the invasion and migration of gastric cancer.

Wang RF, Zhang LH, Shan LH, Sun WG, Chai CC, Wu HM, Ibla JC, Wang LF, Liu JR.

Exp Mol Pathol. 2013 Dec;95(3):350-56.

PMID:
24422232
6.

Fibroblast activation protein regulates tumor-associated fibroblasts and epithelial ovarian cancer cells.

Lai D, Ma L, Wang F.

Int J Oncol. 2012 Aug;41(2):541-50. doi: 10.3892/ijo.2012.1475. Epub 2012 May 14.

PMID:
22614695
7.

Clinical implications of fibroblast activation protein-α in non-small cell lung cancer after curative resection: a new predictor for prognosis.

Liao Y, Ni Y, He R, Liu W, Du J.

J Cancer Res Clin Oncol. 2013 Sep;139(9):1523-8. doi: 10.1007/s00432-013-1471-8. Epub 2013 Jul 9.

PMID:
23835897
8.

The utility of ATF3 in distinguishing cutaneous squamous cell carcinoma among other cutaneous epithelial neoplasms.

Rose CL, Chakravarti N, Curry JL, Torres-Cabala CA, Bassett R, Prieto VG, Tetzlaff MT.

J Cutan Pathol. 2012 Aug;39(8):762-8. doi: 10.1111/j.1600-0560.2012.01938.x. Epub 2012 Jul 5.

PMID:
22764884
9.

Increased expression of CCN2, epithelial membrane antigen, and fibroblast activation protein in hepatocellular carcinoma with fibrous stroma showing aggressive behavior.

Kim GJ, Rhee H, Yoo JE, Ko JE, Lee JS, Kim H, Choi JS, Park YN.

PLoS One. 2014 Aug 15;9(8):e105094. doi: 10.1371/journal.pone.0105094. eCollection 2014.

10.

p53 protein expression and cell proliferation in non-neoplastic and neoplastic proliferative skin diseases.

Batinac T, Zamolo G, Jonjić N, Gruber F, Petrovecki M.

Tumori. 2004 Jan-Feb;90(1):120-7.

PMID:
15143984
11.

The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers.

Sellheyer K, Nelson P, Kutzner H, Patel RM.

J Cutan Pathol. 2013 Apr;40(4):363-70. doi: 10.1111/cup.12085. Epub 2013 Feb 11.

PMID:
23398472
12.

Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.

Dienus K, Bayat A, Gilmore BF, Seifert O.

Arch Dermatol Res. 2010 Dec;302(10):725-31. doi: 10.1007/s00403-010-1084-x. Epub 2010 Sep 26.

PMID:
20872224
13.

Expression of drebrin, an actin binding protein, in basal cell carcinoma, trichoblastoma and trichoepithelioma.

Mizutani Y, Iwamoto I, Kanoh H, Seishima M, Nagata K.

Histol Histopathol. 2014 Jun;29(6):757-66. Epub 2013 Dec 18.

PMID:
24346822
14.

Malignant potential of keratoacanthoma.

Butcher RB 2nd.

Laryngoscope. 1979 Jul;89(7 Pt 1):1092-8.

PMID:
449552
15.

Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug.

Brennen WN, Rosen DM, Wang H, Isaacs JT, Denmeade SR.

J Natl Cancer Inst. 2012 Sep 5;104(17):1320-34. doi: 10.1093/jnci/djs336. Epub 2012 Aug 21.

16.

Cell proliferation and p53 protein expressions in cutaneous epithelial neoplasms.

Onodera H, Nakamura S, Sugai T.

Am J Dermatopathol. 1996 Dec;18(6):580-8.

PMID:
8989929
17.

PHLDA1 (TDAG51) is a follicular stem cell marker and differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma.

Sellheyer K, Krahl D.

Br J Dermatol. 2011 Jan;164(1):141-7. doi: 10.1111/j.1365-2133.2010.10045.x. Epub 2010 Dec 6.

PMID:
20846311
18.

Immunohistochemical expression of ezrin in cutaneous basal and squamous cell carcinomas.

Abdou AG, Maraee AH, El-Sayed EM, Elnaidany NF.

Ann Diagn Pathol. 2011 Dec;15(6):394-401. doi: 10.1016/j.anndiagpath.2011.05.005. Epub 2011 Aug 16.

PMID:
21849257
19.

Expression of CD10 in basal cell carcinoma.

Yada K, Kashima K, Daa T, Kitano S, Fujiwara S, Yokoyama S.

Am J Dermatopathol. 2004 Dec;26(6):463-71.

PMID:
15618927
20.

Immunohistochemical expression of MCM2 in nonmelanoma epithelial skin cancers.

Abdou AG, Elwahed MG, Serag El-Dien MM, Eldien DS.

Am J Dermatopathol. 2014 Dec;36(12):959-64. doi: 10.1097/DAD.0000000000000114.

PMID:
24936676
Items per page

Supplemental Content

Write to the Help Desk